2026-04-25T13:48:50Z
https://www.pub.unibl.org/oai
oai:pub.unibl.org:39922
2026-01-06T04:43:31Z
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
/unibl/author/R Fleischmann
/unibl/author/E Mysler
/unibl/author/S Hall
/unibl/author/AJ Kivitz
/unibl/author/RJ Moots
/unibl/author/Z Luo
/unibl/author/R DeMasi
/unibl/author/K Soma
/unibl/author/R Zhang
/unibl/author/L Takiya
/unibl/author/S Tatulych
/unibl/author/C Mojcik
/unibl/author/S Krishnaswami
/unibl/author/S Menon
/unibl/author/JS Smolen
https://www.unibl.org/sr-lat/fis/zaposlen/3403-ljubinka-bozic
2017-07
Academic Article
text
468
457
/unibl/sci/idNaucniRad:24623
LANCET, THE
0140-6736
LANCET, THE
0140-6736
R. Fleischmann, E. Mysler, S. Hall, A. Kivitz, R. Moots, Z. Luo, R. DeMasi, K. Soma, R. Zhang, L. Takiya, S. Tatulych, C. Mojcik, S. Krishnaswami, S. Menon, J. Smolen, LJ. Božić, Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial, LANCET, THE, pp. 457 - 468, Jul, 2017